ATE326978T1 - Apoptose-imitierende natürliche vesikel und deren verwendung zur medizinischen behandlung - Google Patents

Apoptose-imitierende natürliche vesikel und deren verwendung zur medizinischen behandlung

Info

Publication number
ATE326978T1
ATE326978T1 AT02759995T AT02759995T ATE326978T1 AT E326978 T1 ATE326978 T1 AT E326978T1 AT 02759995 T AT02759995 T AT 02759995T AT 02759995 T AT02759995 T AT 02759995T AT E326978 T1 ATE326978 T1 AT E326978T1
Authority
AT
Austria
Prior art keywords
apoptosis
medical treatment
disorders
mimic natural
vesicles
Prior art date
Application number
AT02759995T
Other languages
English (en)
Inventor
Anthony E Bolton
Arkady Mandel
Original Assignee
Vasogen Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vasogen Ireland Ltd filed Critical Vasogen Ireland Ltd
Application granted granted Critical
Publication of ATE326978T1 publication Critical patent/ATE326978T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02759995T 2001-09-18 2002-09-13 Apoptose-imitierende natürliche vesikel und deren verwendung zur medizinischen behandlung ATE326978T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32381801P 2001-09-18 2001-09-18

Publications (1)

Publication Number Publication Date
ATE326978T1 true ATE326978T1 (de) 2006-06-15

Family

ID=23260849

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02759995T ATE326978T1 (de) 2001-09-18 2002-09-13 Apoptose-imitierende natürliche vesikel und deren verwendung zur medizinischen behandlung

Country Status (10)

Country Link
US (1) US20060035809A1 (de)
EP (1) EP1427428B1 (de)
AT (1) ATE326978T1 (de)
AU (1) AU2002325739A1 (de)
CA (1) CA2460098A1 (de)
DE (1) DE60211721T2 (de)
DK (1) DK1427428T3 (de)
ES (1) ES2268071T3 (de)
PT (1) PT1427428E (de)
WO (1) WO2003024419A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1773381A4 (de) * 2004-07-01 2008-07-02 Univ Pittburgh Of The Commonwe Immunsuppressive exosome
WO2006059329A1 (en) * 2004-12-01 2006-06-08 Hadasit Medical Research Services & Development Limited Platelet-derived microparticles for therapy
WO2006107107A1 (ja) * 2005-04-01 2006-10-12 Fumitaka Ohsuzu リン脂質小胞体を含む心筋保護剤および虚血・再潅流時の心筋障害を予防する方法
US20090297485A1 (en) * 2008-05-28 2009-12-03 Allan Mishra Compositions and methods for treating psychiatric and neurodegenerative disorders
WO2015069897A1 (en) * 2013-11-07 2015-05-14 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Red blood cell membrane-derived microparticles and their use for the treatment of lung disease
KR101720851B1 (ko) * 2015-01-29 2017-03-28 포항공과대학교 산학협력단 세포의 지질막에서 유래된 나노소포체 및 이의 용도
US11357800B2 (en) 2016-08-16 2022-06-14 Henry Ford Health System Compositions for the treatment of neuropathic pain and sensitization of tumors to chemotherapies
CN114591905B (zh) * 2022-04-01 2022-09-02 北京大学口腔医学院 一种人红细胞制备凋亡囊泡的方法与应用
WO2024080931A1 (en) * 2022-10-11 2024-04-18 National University Of Singapore Anti-inflammatory red blood cell extracellular vesicles (rbcevs)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2331115A1 (en) * 1998-05-11 1999-11-18 Inserm (Institut De La Sante Et De La Recherche Medicale) New apoptotic bodies, monocyte derived cells containing the same, a process for their preparation and their uses as vaccines

Also Published As

Publication number Publication date
ES2268071T3 (es) 2007-03-16
AU2002325739A1 (en) 2003-04-01
CA2460098A1 (en) 2003-03-27
DE60211721T2 (de) 2007-05-24
WO2003024419B1 (en) 2003-10-30
DE60211721D1 (de) 2006-06-29
PT1427428E (pt) 2006-10-31
WO2003024419A3 (en) 2003-09-18
EP1427428A2 (de) 2004-06-16
US20060035809A1 (en) 2006-02-16
DK1427428T3 (da) 2006-09-25
WO2003024419A2 (en) 2003-03-27
EP1427428B1 (de) 2006-05-24

Similar Documents

Publication Publication Date Title
Heilig et al. Caspase-1 cleaves Bid to release mitochondrial SMAC and drive secondary necrosis in the absence of GSDMD
Loi et al. The effects of immunomodulation by macrophage subsets on osteogenesis in vitro
Alcaraz et al. Extracellular vesicles from mesenchymal stem cells as novel treatments for musculoskeletal diseases
Romano et al. Expanded regulatory T cells induce alternatively activated monocytes with a reduced capacity to expand T helper-17 cells
Qin et al. Blocking P2X7-mediated macrophage polarization overcomes treatment resistance in lung cancer
Mallat et al. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein e–knockout mice
Goldstein History of the discovery of the thymosins
Rock et al. The sterile inflammatory response
DeMarco et al. Monocytes promote natural killer cell interferon gamma production in response to the endogenous danger signal HMGB1
Edgerton et al. IL-17 producing CD4+ T cells mediate accelerated ischemia/reperfusion-induced injury in autoimmunity-prone mice
Castellano et al. An overview of l-amino acid oxidase functions from bacteria to mammals: focus on the immunoregulatory phenylalanine oxidase IL4I1
Yamamoto et al. Cutting edge: Pseudomonas aeruginosa abolishes established lung transplant tolerance by stimulating B7 expression on neutrophils
Campos-Mora et al. CD4+ Foxp3+ T regulatory cells promote transplantation tolerance by modulating effector CD4+ T cells in a neuropilin-1-dependent manner
Kim et al. Extracellular vesicles derived from the periodontal pathogen Filifactor alocis induce systemic bone loss through Toll‐like receptor 2
Lo Monaco et al. Therapeutic potential of dental pulp stem cells and leukocyte-and platelet-rich fibrin for osteoarthritis
Kweon et al. Inhibition of foreign body giant cell formation by 4-hexylresorcinol through suppression of diacylglycerol kinase delta gene expression
De Reuck et al. Lysosomes
Garzón-Tituaña et al. Granzyme A inhibition reduces inflammation and increases survival during abdominal sepsis
DE60211721D1 (de) Apoptose-imitierende natürliche vesikel und deren verwendung zur medizinischen behandlung
Huang et al. Conditioned medium from M2b macrophages modulates the proliferation, migration, and apoptosis of pulmonary artery smooth muscle cells by deregulating the PI3K/Akt/FoxO3a pathway
Barbeck et al. Exploring the biomaterial-induced secretome: Physical bone substitute characteristics influence the cytokine expression of macrophages
Yang et al. Inflammasomes and the maintenance of hematopoietic homeostasis: new perspectives and opportunities
Rea et al. Triple jeopardy in ageing: COVID-19, co-morbidities and inflamm-ageing
McClain Caldwell et al. Bone marrow-derived mesenchymal stromal cells (MSCs) modulate the inflammatory character of alveolar macrophages from sarcoidosis patients
Simpson et al. Plasmacytoid dendritic cells respond directly to apoptotic cells by secreting immune regulatory IL-10 or IFN-α

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1427428

Country of ref document: EP

REN Ceased due to non-payment of the annual fee